Table 1.
Characteristics of the study population (n=265)
| Characteristic | Result |
|---|---|
| Median age at surgery, years (IQR) | 60.3 (54.2-70.2) |
| Median hemoglobin, g/dl (IQR) | 11.90 (10.3-13.4) |
| Median corrected Ca, mg/dl (IQR) | 9.30 (9.1-9.8) |
| Median LDH (IU/L) (IQR) | 522.0 (422-693) |
| Median creatinine, mg/dl (IQR) | 1.30 (1.0-1.5) |
| Median length of stay, days (IQR) | 8.00 (6.0-13.0) |
| Sex, n (%) | |
| Male | 175 (66.0) |
| Female | 90 (34.0) |
| Race and ethnicity, n (%) | |
| White | 197 (74.3) |
| Hispanic | 55 (20.8) |
| Black | 10 (3.8) |
| Asian | 3 (1.1) |
| Clinical T stage, n (%) | |
| 3b | 224 (84.5) |
| 3c | 41 (15.5) |
| Clinical N1 | 46 (17.4) |
| Clinical M1 | 120 (45.3) |
| Pre-surgery embolization, n (%) | 50 (18.9) |
| Histologic type, n (%) | |
| Clear cell | 238 (90.2) |
| Non-clear cell | 27 (9.9) |
| Grade, n (%) | |
| 0-2 | 25 (9.5) |
| 3 | 118 (45.0) |
| 4 | 119 (45.4) |
| Sarcomatoid, n (%) | 29 (11.0) |
| Rhabdoid, n (%) | 13 (5.0) |
| Congestive heart failure, n (%) | 2 (0.8) |
| Cytoreductive nephrectomy, n (%) | 120 (45.3) |
| Side, n (%) | |
| Right | 80 (30.2) |
| Left | 184 (69.4) |
| Both | 1 (0.4) |
| Hypertension, n (%) | 135 (50.9) |
| Diabetes mellitus, n (%) | 51 (19.3) |
| Coronary artery disease, n (%) | 26 (9.8) |
| Peripheral vascular disease, n (%) | 2 (0.8) |
| Hematuria, n (%) | |
| Microhematuria | 13 (4.9) |
| Gross hematuria | 106 (40.2) |
| Flank pain, n (%) | 78 (29.6) |
| Weight loss >10 lbs, n (%) | 81 (30.7) |
| Malaise weakness fatigue, n (%) | 81 (30.7) |
| Bilateral leg edema, n (%) | 40 (15.2) |
| New-onset congestive heart failure, n (%) | 13 (4.9) |